Application

17587941 · FACTOR VIII-FC CHIMERIC AND HYBRID POLYPEPTIDES, AND METHODS OF USE THEREOF

Filed 2022-01-28 · Pending The official file ↗ · Art unit 1641 · Examiner Michael Edward Szperka Typical · CPC A61K 38/37 · BIOVERATIV THERAPEUTICS INC. · Lathrop GPM LLP | Sanofi-Aventis

Office actions

first was Non-final rejection

RCEs

appealed

To first action

35.6 mo

to disposition n/a

Statutes raised

102 103 112 DP

4 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.